Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Ticker
Market factors today
Unlock the full SHPH picture
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
SHPH stock facts
| Ticker symbol | SHPH |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market cap | $2.4M |
| CEO | Christopher Robert Cooper |
| Employees | 2 |
| Headquarters | Gaithersburg, MD, US |
| IPO date | 2022-08-31 |
| Website | www.shuttlepharma.com |
What you can see for SHPH on Tickr
Live SHPH price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the SHPH report.
Rankings
FAQ
What is the ticker symbol for Shuttle Pharmaceuticals Holdings, Inc.?
The ticker symbol for Shuttle Pharmaceuticals Holdings, Inc. is SHPH, listed on the NASDAQ Global Market.
What is SHPH?
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.